Despite a thaw in trade talks, higher costs, logistics challenges and refinery constraints may limit any near-term boost in India's crude oil, gas and LPG imports from the US
E-commerce and quick commerce platforms are set to add nearly a million gig workers in 2026, driven by last-mile delivery demand and rapid expansion of dark stores in non-metro cities
Goyal said India would face no difficulty in purchasing goods worth $500 billion from the United States over the next five years under a proposed bilateral trade pact
An analysis by CITI of data from the US Office of Textiles and Apparel showed that US imports of textiles and apparel from India fell 31.4 per cent in November 2025 compared with November 2024
What remains unclear is whether American soybean oil will be allowed on a quota basis with nil basic customs duty, and whether the 6.5 per cent agri and education cess will be exempted
Indian Oil, Bharat Petroleum and Reliance Industries are not accepting offers from traders for Russian oil loading in March and April, said a trader who approached the refiners
According to a joint statement, India and the US have agreed on a framework for the first phase of the bilateral trade agreement, which is expected to be signed by mid-March
The proposed safe harbour regime for component warehousing linked to manufacturing may offer multinationals a globally competitive tax outcome and greater certainty on transfer pricing
India-US interim trade framework cuts tariffs on several agricultural items, but Commerce Minister Piyush Goyal said sensitive products such as apples, soybean oil and DDGS will be capped under quotas
Addressing a press conference, the Union Minister said that several Indian goods will attract zero duties on export, including pharmaceutical products and smartphones
Addressing a press conference, the commerce minister hailed the India-US trade framework, adding that it protects farmers, boosts exports, and strengthens bilateral trade ties
India's pharmaceutical exports to the US are unlikely to see major tariff changes under the interim pact as Section 232 investigations continue, though medical devices may gain from better access